- UK medicines regulator needs more resources.
- Big money for biosimilars.
- Fixing liberalism.
- 2024 scientific breakthroughs.
- The Economist: Best books of 2024.
AstraZeneca’s Calquence has expanded its FDA approval to include first-line treatment of...
ByglobalreutersJanuary 17, 2025This interactive chart allows users to track public opinion on the Affordable...
ByglobalreutersJanuary 17, 2025Teladoc Health has joined Amazon’s Health Benefits Connector. Other companies offered through...
ByglobalreutersJanuary 17, 2025
Leave a comment